BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1454 related articles for article (PubMed ID: 15734613)

  • 1. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
    Adabag AS; Maron BJ; Appelbaum E; Harrigan CJ; Buros JL; Gibson CM; Lesser JR; Hanna CA; Udelson JE; Manning WJ; Maron MS
    J Am Coll Cardiol; 2008 Apr; 51(14):1369-74. PubMed ID: 18387438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmias and sudden death after dynamic cardiomyoplasty.
    Bocchi EA; Moreira LF; de Moraes AV; Bacal F; Sosa E; Stolf NA; Bellotti G; Jatene AD; Pilleggi F
    Circulation; 1994 Nov; 90(5 Pt 2):II107-11. PubMed ID: 7955235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
    Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
    Olivotto I; Montereggi A; Mazzuoli F; Cecchi F
    G Ital Cardiol; 1999 Jan; 29(1):11-9. PubMed ID: 9987042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil.
    Arteaga E; Ianni BM; Fernandes F; Mady C
    Am Heart J; 2005 Jun; 149(6):1099-105. PubMed ID: 15976794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Gregori D; Moretti M; Driussi M; Aleksova A; Chersevani D; Sabbadini G; Sinagra G
    Ital Heart J; 2005 Sep; 6(9):721-7. PubMed ID: 16212073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes.
    Biffi A; Maron BJ; Verdile L; Fernando F; Spataro A; Marcello G; Ciardo R; Ammirati F; Colivicchi F; Pelliccia A
    J Am Coll Cardiol; 2004 Sep; 44(5):1053-8. PubMed ID: 15337218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Grimm W; Christ M; Maisch B
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S207-10. PubMed ID: 15683498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?
    Zecchin M; Di Lenarda A; Gregori D; Merlo M; Pivetta A; Vitrella G; Sabbadini G; Mestroni L; Sinagra G
    Pacing Clin Electrophysiol; 2008 Mar; 31(3):290-9. PubMed ID: 18307623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy.
    O'Mahony C; Lambiase PD; Rahman SM; Cardona M; Calcagnino M; Quarta G; Tsovolas K; Al-Shaikh S; McKenna W; Elliott P
    Europace; 2012 May; 14(5):724-33. PubMed ID: 22094454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of sudden death in heart failure patients: a novel perspective from the assessment of the peak ectopy rate.
    Casaleggio A; Maestri R; La Rovere MT; Rossi P; Pinna GD
    Europace; 2007 Jun; 9(6):385-90. PubMed ID: 17437967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.